Outcome of patients with ductal carcinoma in situ and sentinel node biopsy

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2345-2351

  Meretoja, T J ^a   Heikkila P S ^a   Salmenkivi, K ^a   Leidenius, M H K ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLA METASTASIS; AXILLARY LYMPH NODE; CANCER PROGNOSIS; CANCER RECURRENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE MACROMETASTASIS; SENTINEL LYMPH NODE METASTASIS; SENTINEL LYMPH NODE MICROMETASTASIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM MICROMETASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY;

EID: 84865138731     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2287-5     Document Type: Article

References (32)

1. Silverstein MJ. Ductal carcinoma in situ of the breast. Annu Rev Med. 2000;51:17-32. (Pubitemid 30216023)
2. Cox CE, Nguyen K, Gray RJ, Salud C, Ku NN, Dupont E, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2001;67:513-19; discussion 519-21. (Pubitemid 33738842)
3. Intra M, Veronesi P, Mazzarol G, Galimberti V, Luini A, Sac-chini V, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg. 2003;138:309-13. (Pubitemid 36292666)
4. Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in situ and ductal car-cinoma-in situ with microinvasion? Ann Surg Oncol. 2000;7: 636-42.
5. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg. 2005;62:253-7. (Pubitemid 40425295)
6. Pendas S, Dauway E, Giuliano R, Ku N, Cox CE, Reintgen DS. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol. 2000;7:15-20. (Pubitemid 30078488)
7. Veronesi P, Intra M, Vento AR, Naninato P, Caldarella P, Pa-ganelli G, et al. Sentinel lymph node biopsy for localised ductal carcinoma in situ? Breast. 2005;14:520-2. (Pubitemid 41683574)
8. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005;200:516-26. (Pubitemid 40432319)
9. Zavagno G, Carcoforo P, Marconato R, Franchini Z, Scalco G, Burelli P, et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer. 2005;5:28.
10. Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010:139-41.
11. Leidenius MH, Krogerus LA, Toivonen TS, von Smitten KA. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol. 2005;31:364-8. (Pubitemid 40521300)
12. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg. 2005;241:319-25.
13. Cserni G, Gregori D, Merletti F, Sapino A, Mano MP, Ponti A, et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Surg. 2004;91:1245-52. (Pubitemid 39331448)
14. Christiansen P, Friis E, Balslev E, Jensen D, Moller S. Sentinel node biopsy in breast cancer: five years experience from Denmark. Acta Oncol. 2008;47:561-8. (Pubitemid 351878457)
15. Leidenius MH, Vironen JH, Riihela MS, Krogerus LA, Toivonen TS, von Smitten KA, et al. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node microm-etastases. Eur J Surg Oncol. 2005;31:13-8. (Pubitemid 40103919)
16. Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer. 1997;80:1798-802.
17. Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, et al. Prognostic classification of breast ductal car-cinoma-in situ. Lancet. 1995;345:1154-7.
18. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumours. 6th ed. New-York: Wiley-Liss, 2002.
19. Murphy CD, Jones JL, Javid SH, Michaelson JS, Nolan ME, Lipsitz SR, et al. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg. 2008;196:566-8.
20. Broekhuizen LN, Wijsman JH, Peterse JL, Rutgers EJ. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol. 2006;32:502-6.
21. Moore KH, Sweeney KJ, Wilson ME, Goldberg JI, Buchanan CL, Tan LK, et al. Outcomes for women with ductal carcinoma-in situ and a positive sentinel node: a multi-institutional audit. Ann Surg Oncol. 2007;14:2911-7. (Pubitemid 47460624)
22. Intra M, Rotmensz N, Veronesi P, Colleoni M, Iodice S, Paga-nelli G, et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg. 2008;247:315-9. (Pubitemid 351156776)
23. Leikola JP, Toivonen TS, Krogerus LA, von Smitten KA, Le-idenius MH. Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer. 2005;104:14-9. (Pubitemid 40847747)
24. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252: 426-32; discussion 432-3.
25. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305: 569-75.
26. Hansen NM, Ye X, Grube BJ, Giuliano AE. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg. 2004;139:634-9; discussion 639-40.
27. Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004;28:1641-5. (Pubitemid 39564971)
28. Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumen-cranz PW, Reintgen DS, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011;306: 385-93.
29. Tan JC, McCready DR, Easson AM, Leong WL. Role of sentinel lymph node biopsy in ductal carcinoma-in situ treated by mastectomy. Ann Surg Oncol. 2007;14:638-45. (Pubitemid 46175309)
30. Cody HS, Klauber-Demore N, Borgen PI, Van Zee KJ. Is it really duct carcinoma in situ? Ann Surg Oncol. 2001;8:617-9. (Pubitemid 32847923)
31. Intra M, Veronesi P, Gentilini OD, Trifirò G, Berrettini A, Cecilio R, et al. Sentinel lymph node biopsy is feasible even after total mastectomy. J Surg Oncol. 2007;95:175-9. (Pubitemid 46238989)
32. Karam A, Stempel M, Cody HS, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207:543-8.